JP5453559B1 - 晶癖を有する結晶及び該結晶を加工してなる医薬組成物 - Google Patents

晶癖を有する結晶及び該結晶を加工してなる医薬組成物 Download PDF

Info

Publication number
JP5453559B1
JP5453559B1 JP2013081346A JP2013081346A JP5453559B1 JP 5453559 B1 JP5453559 B1 JP 5453559B1 JP 2013081346 A JP2013081346 A JP 2013081346A JP 2013081346 A JP2013081346 A JP 2013081346A JP 5453559 B1 JP5453559 B1 JP 5453559B1
Authority
JP
Japan
Prior art keywords
crystal
plane
luliconazole
present
habit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013081346A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014074008A (ja
Inventor
孝明 増田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Original Assignee
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nihon Nohyaku Co Ltd filed Critical Pola Pharma Inc
Priority to JP2013081346A priority Critical patent/JP5453559B1/ja
Application granted granted Critical
Publication of JP5453559B1 publication Critical patent/JP5453559B1/ja
Publication of JP2014074008A publication Critical patent/JP2014074008A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2013081346A 2012-09-14 2013-04-09 晶癖を有する結晶及び該結晶を加工してなる医薬組成物 Active JP5453559B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013081346A JP5453559B1 (ja) 2012-09-14 2013-04-09 晶癖を有する結晶及び該結晶を加工してなる医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012202516 2012-09-14
JP2012202516 2012-09-14
JP2013081346A JP5453559B1 (ja) 2012-09-14 2013-04-09 晶癖を有する結晶及び該結晶を加工してなる医薬組成物

Publications (2)

Publication Number Publication Date
JP5453559B1 true JP5453559B1 (ja) 2014-03-26
JP2014074008A JP2014074008A (ja) 2014-04-24

Family

ID=47278492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013081346A Active JP5453559B1 (ja) 2012-09-14 2013-04-09 晶癖を有する結晶及び該結晶を加工してなる医薬組成物

Country Status (7)

Country Link
US (1) US9199977B2 (cg-RX-API-DMAC7.html)
EP (1) EP2895479A1 (cg-RX-API-DMAC7.html)
JP (1) JP5453559B1 (cg-RX-API-DMAC7.html)
CN (1) CN104619703A (cg-RX-API-DMAC7.html)
IN (1) IN2015DN02376A (cg-RX-API-DMAC7.html)
RU (1) RU2603963C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014041708A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5589130B1 (ja) * 2012-09-14 2014-09-10 株式会社ポーラファルマ 結晶及び該結晶を含有してなる医薬製剤

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5688405B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
CN102387786B (zh) 2009-04-09 2015-09-09 宝丽制药股份有限公司 抗真菌药物组合物
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102933201B (zh) 2010-06-11 2015-12-16 宝丽制药股份有限公司 抗真菌药物组合物
CN104619704B (zh) 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5589110B1 (ja) * 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5951864B1 (ja) * 2015-06-05 2016-07-13 株式会社ポーラファルマ 抗ジアルジア剤
JP2017101009A (ja) * 2015-12-04 2017-06-08 株式会社ポーラファルマ 抗アカントアメーバ剤及びその製造法
JP6085706B1 (ja) * 2016-03-31 2017-02-22 株式会社ポーラファルマ 抗トリトリコモナス剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
KR100386491B1 (ko) * 1995-07-08 2003-08-21 니혼노야쿠가부시키가이샤 항진균제,이를위한화합물및이의제조방법
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
RU2415669C2 (ru) 2006-03-08 2011-04-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
BRPI0621446C1 (pt) 2006-03-08 2021-05-25 Nihon Nohyaku Co Ltd composição farmacêutica para uso externo
AU2006339841B2 (en) * 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
WO2009031643A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
KR20100075475A (ko) 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 의약 조성물
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
EP2395839B1 (en) * 2009-02-13 2014-05-07 Topica Pharmaceuticals, Inc Anti-fungal formulation
CN102387786B (zh) * 2009-04-09 2015-09-09 宝丽制药股份有限公司 抗真菌药物组合物
JP5688405B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102933201B (zh) 2010-06-11 2015-12-16 宝丽制药股份有限公司 抗真菌药物组合物
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
CN104619320A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 含有卢立康唑的药物组合物
CN104619704B (zh) 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物
US9012484B2 (en) 2012-09-14 2015-04-21 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5589130B1 (ja) * 2012-09-14 2014-09-10 株式会社ポーラファルマ 結晶及び該結晶を含有してなる医薬製剤

Also Published As

Publication number Publication date
IN2015DN02376A (cg-RX-API-DMAC7.html) 2015-09-04
EP2895479A1 (en) 2015-07-22
RU2603963C2 (ru) 2016-12-10
JP2014074008A (ja) 2014-04-24
US20150183766A1 (en) 2015-07-02
WO2014041708A1 (en) 2014-03-20
US9199977B2 (en) 2015-12-01
CN104619703A (zh) 2015-05-13
RU2015109127A (ru) 2016-11-10

Similar Documents

Publication Publication Date Title
JP5453559B1 (ja) 晶癖を有する結晶及び該結晶を加工してなる医薬組成物
JP5589130B1 (ja) 結晶及び該結晶を含有してなる医薬製剤
US20220048848A1 (en) Polymorphic forms of rad1901-2hcl
EP2873664B1 (en) Crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof
WO2004022538A1 (ja) 経口用固形医薬用結晶およびそれを含む排尿障害治療用経口用固形医薬
EP3327012B1 (en) Crystalline forms of bilastine and preparation methods thereof
JP2024001115A (ja) オキサゾール化合物結晶
US10556863B1 (en) Crystalline form of (R)-4-hydroxy-2-oxo-1-pyrrolidineacetamide, preparation method therefor and use thereof
EP3530272A1 (en) Novel crystalline form of dextral oxiracetam, preparation method therefor and use thereof
EP2558440B1 (en) Process for the production of polymorph form i of agomelatine
JP5698395B2 (ja) 結晶及び該結晶を含有してなる医薬製剤
WO2025241792A1 (zh) 艾拉司群二盐酸盐的新晶型及其制备方法和用途
EP4592277A2 (en) Co-crystalline efinaconazole, and method for producing same
TWI241289B (en) Suplatast tosilate crystals
JP5680161B1 (ja) 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
EP3348546B1 (en) Crystalline form of androgen receptor inhibitor and preparation method thereof
JP5795693B2 (ja) 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
KR20170066196A (ko) 항아칸트아메바제 및 그 제조방법
CN107141253A (zh) 一种阿立哌唑倍半水合物化合物
CN104356036A (zh) 消旋卡多曲α 晶型及其制备方法
JP2021001140A (ja) 安定なアジルサルタン微細結晶の製造方法
HK1223568B (zh) 齐留通乳膏剂型的局部用抗炎症药学组合物
TW201518276A (zh) 吲哚衍生物之鹽及其結晶

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140106

R150 Certificate of patent or registration of utility model

Ref document number: 5453559

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250